RPAM
ZBH icon

Rhenman & Partners Asset Management’s Zimmer Biomet ZBH Stock Holding History

Rhenman & Partners Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-87,250
Closed -$9.87M – 105
2025
Q1 		$9.87M Sell
87,250
-36,750
-30% -$3.93M 1.14% 33
2024
Q4 		$13.1M Buy
+124,000
New +$13.3M 1.35% 30
2024
Q2 		– Sell
-67,500
Closed -$8.91M – 96
2024
Q1 		$8.91M Buy
67,500
+12,500
+23% +$1.56M 0.84% 43
2023
Q4 		$6.69M Sell
55,000
-5,000
-8% -$558K 0.67% 49
2023
Q3 		$6.73M Sell
60,000
-78,000
-57% -$9.91M 0.73% 42
2023
Q2 		$20.1M Buy
+138,000
New +$18.8M 2.12% 19
2022
Q1 		– Sell
-92,700
Closed -$11.5M – 94
2021
Q4 		$11.5M Sell
92,700
-30,900
-25% -$4.04M 0.77% 48
2021
Q3 		$17.6M Sell
123,600
-20,600
-14% -$3.03M 1.23% 36
2021
Q2 		$22.5M Buy
144,200
+10,300
+8% +$1.67M 1.53% 24
2021
Q1 		$20.8M Buy
133,900
+66,950
+100% +$10.4M 1.45% 28
2020
Q4 		$10M Sell
66,950
-17,510
-21% -$2.47M 0.82% 50
2020
Q3 		$11.2M Buy
84,460
+25,750
+44% +$3.36M 0.99% 42
2020
Q2 		$6.8M Sell
58,710
-23,690
-29% -$2.73M 0.74% 52
2020
Q1 		$8.09M Buy
+82,400
New +$10.8M 1.13% 40
2017
Q3 		– Sell
-92,700
Closed -$11.6M – 108
2017
Q2 		$11.6M Buy
92,700
+20,600
+29% +$2.44M 1.66% 22
2017
Q1 		$8.55M Sell
72,100
-10,300
-13% -$1.17M 1.35% 31
2016
Q4 		$8.26M Sell
82,400
-5,150
-6% -$552K 1.58% 23
2016
Q3 		$11.1M Buy
87,550
+14,420
+20% +$1.78M 1.76% 18
2016
Q2 		$8.55M Sell
73,130
-20,600
-22% -$2.33M 1.52% 22
2016
Q1 		$9.7M Sell
93,730
-16,480
-15% -$1.59M 1.93% 15
2015
Q4 		$11M Buy
110,210
+38,110
+53% +$3.73M 1.66% 24
2015
Q3 		$6.58M Buy
+72,100
New +$7.23M 1.05% 40
2014
Q3 		– Sell
-23,175
Closed -$2.34M – 103
2014
Q2 		$2.34M Buy
+23,175
New +$2.26M 0.69% 55
2014
Q1 		– Sell
-30,900
Closed -$2.8M – 99
2013
Q4 		$2.8M Buy
+30,900
New +$2.67M 1.09% 30

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Rhenman & Partners Asset Management's ZBH Position: Q2 2025 in Review

Rhenman & Partners Asset Management sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 87,250 shares — an estimated $9.87M sold.

Rhenman & Partners Asset Management first reported a position in ZBH in Q4 2013 and held it in 24 quarters. The position peaked at $22.5M in Q2 2021. 935 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • Rhenman & Partners Asset Management reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 87,250 Zimmer Biomet shares in Q2 2025, an estimated $9.87M.
  • Rhenman & Partners Asset Management first reported a position in Zimmer Biomet in Q4 2013 and held it in 24 quarters.
  • Rhenman & Partners Asset Management's Zimmer Biomet position peaked at $22.5M in Q2 2021.
  • 935 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.